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Abstract The rate of amino acid efflux from individual
cells needs to be adapted to cellular demands and plays a
central role for the control of extracellular amino acid
homeostasis. A particular example of such an outward
amino acid transport is the basolateral efflux from trans-
porting epithelial cells located in the small intestine and
kidney proximal tubule. Because LAT2-4F2hc (Slc7a8–
Slc3a2), the best known basolateral neutral amino acid
transporter of these epithelial cells, functions as an
obligatory exchanger, we tested whether TAT1 (Slc16a10),
the aromatic amino-acid facilitated diffusion transporter,
might allow amino acid efflux via this exchanger by
recycling its influx substrates. In this study, we show by
immunofluorescence that TAT1 and LAT2 indeed colo-
calize in the early kidney proximal tubule. Using the
Xenopus laevis oocytes expression system, we show that L-
glutamine is released from oocytes into an amino-acid-free
medium only when both transporters are coexpressed.
High-performance liquid chromatography analysis reveals
that several other neutral amino acids are released as well.
The transport function of both TAT1 and LAT2-4F2hc is
necessary for this efflux, as coexpression of functionally
inactive but surface-expressed mutants is ineffective. Based
on negative results of coimmunoprecipitation and cross-
linking experiments, the physical interaction of these
transporters does not appear to be required. Furthermore,
replacement of TAT1 or LAT2-4F2hc by the facilitated
diffusion transporter LAT4 or the obligatory exchanger
LAT1, respectively, supports similar functional cooperation.
Taken together, the results suggest that the aromatic amino
acid diffusion pathway TAT1 can control neutral amino
acid efflux via neighboring exchanger LAT2-4F2hc, by
recycling its aromatic influx substrates.
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Introduction
Transcellular absorption of neutral amino acids from the
lumen of the small intestine and reabsorption from the
primary urinary filtrate of the kidney proximal tubule
involves transport across two sequential membranes. Apical
uptake from the lumen into epithelial cells against a con-
centration gradient is mediated by secondary and tertiary
active transporters, whereas basolateral efflux into the
extracellular space is thought to be driven by the amino
acid concentration gradient [28]. The major player for the
luminal neutral amino acid uptake is B0AT1 (Slc6a19),
which catalyzes the Na+-dependent secondary active trans-
port of most neutral amino acids into epithelial cells [4, 5,
15]. The efflux of neutral amino acids across the basolateral
membrane into the extracellular space could potentially
take place entirely via facilitated diffusion pathways.
However, the abundant basolateral amino acid transporters
LAT2-4F2hc and y+LAT1-4F2hc have been shown to
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function as obligatory exchangers [9, 17, 20, 24]. For
that reason, these heterodimeric amino acid transporters
cannot perform net overall amino acid efflux but only net
efflux of specific amino acids provided that others are
taken up. It has been proposed that (a) parallel amino acid
transporter(s), mediating the unidirectional efflux of some
amino acids, may provide heterodimeric exchangers with
influx substrates that would allow them to efflux other
intracellular amino acids [18, 27]. Thus, the heterodimeric
exchangers could be envisaged as modules extending the
efflux selectivity across the membrane, whereas the overall
efflux function would be controlled by the parallel trans-
porters potentially functioning unidirectionally.
For the following several reasons, we considered that
TAT1 (SLC16A10) is a plausible candidate for such a role
as a substrate recycling pathway that may control the efflux
function of basolateral heterodimeric amino acid trans-
porters in small intestine and proximal tubule epithelial
cells. First, the function of TAT1, a member of the Slc16
family of monocarboxylate transporters, was identified as
that of a facilitated diffusion pathway for aromatic amino
acids [13, 14]. In particular, it was shown that it may efflux
L-phenylalanine independent of the presence of extracellu-
lar amino acids, thus being able to perform a unidirectional
transport [13, 22]. Second, we recently showed that TAT1
displays symmetrically low apparent affinities for its
substrates with Km’s in the millimolar range. This implies
that TAT1 can kinetically adapt its transport rate to varying
amino acid concentrations [22]. Third, TAT1 (SLC16A10)
was previously shown to be expressed in the small intestine
and proximal kidney tubule and its expression to be
restricted to the basolateral membrane of these epithelia,
where it colocalizes with 4F2hc and thus probably with
LAT2 [22].
To test the possibility that TAT1 may function as a
recycling pathway to allow and actually control the
function of LAT2-4F2hc and thus to better understand its
physiological role, we first verified its coexpression with
LAT2-4F2hc in the mouse kidney proximal tubule by
immunofluorescence and then addressed the question of its
possible functional cooperation with LAT2-4F2hc and the
potential physical interaction of these transporters using
Xenopus oocytes as an expression system.
Materials and methods
Site-directed mutagenesis of mTAT1 and mLAT2
Functionally inactive mutants of mTAT1 (R340A) and
mLAT2 (E257Q) were created by site-directed mutagenesis
as described previously [10]. Oligonucleotide primer pairs
used were as follows: mLAT2E257Q_for: 5′-CTTAATT
ATGTGACTGAGCAGCTGGTGGATCCTTACAA
GAACC-3′, mLAT2E257Q_rev: 5′-GGTTCTTGTAAGG
ATCCACCAGCTGCTCAGTCACATAATTA AG-3′;
mTAT1R3 4 0A_ f o r : 5 ′ - CACTTCAGGAGTTG
GAGCGCTTCTCTTTGGCCGC-3′, mTAT1R340A_rev:
5 ′ -GCGGCCAAAGAGAAGCGCTCCAACTCCT
GAAGTG-3′. Each reaction consisted of indicated primer
pairs, plasmid templates pSDeasy-mLAT2 or pSDeasy-
mTAT1, respectively, and 2.5% formamide as an additive
[6, 11]. The amplification mixture was treated with DpnI
for 2 h at 37°C, and digested samples were used to
transform Escherichia coli MACH1-T1 (Invitrogen).
Xenopus laevis oocytes and cRNA synthesis
Oocytes were treated with collagenase A1 for 2–3 h at
room temperature (RT) in a Ca2+-free buffer containing
10 mM HEPES, pH 7.4, 82.5 mM NaCl, 2 mM KCl, and
1 mM MgCl2. Oocytes were kept at 16°C in a ND96
solution (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1.8 mM
CaCl2, and 5 mM HEPES/Tris, pH 7.4), supplemented with
50 mg/l of tetracycline. Mouse TAT1 cDNA, R340A TAT1
mutant cDNA, mouse LAT2 cDNA, and E257Q LAT2
mutant cDNA, all in pSDeasy Xenopus oocyte expression
vector, were used for synthesis of cRNA transcripts as
described before [22]. Briefly, plasmids containing the
described cDNAs were linearized using a unique BglII
restriction site. Likewise, the plasmid containing mouse
LAT4 cDNA (in vector pTLN, kindly provided by Palacin)
was linearized using the MluI restriction site, and the
plasmid containing human LAT1 (vector pcDNA/Amp-
pSP64T) was linearized using the EcoRV restriction site.
cRNA was synthesized with SP6 RNA polymerase using
the MEGAscript high-yield transcription kit (Ambion,
Austin, TX) according to the manufacturer’s protocol. The
plasmid containing human 4F2hc cDNA (vector pSport)
was linearized using a unique HindIII restriction site, and
the corresponding cRNA was synthesized using T7 RNA
polymerase.
Measurement of amino acids released by oocytes
Amino acid efflux from oocytes expressing LAT2-4F2hc
and/or TAT1 was measured in the extracellular ND96 buffer
after 24 h incubation. Samples of 200 μl were collected
from a total number of 20 oocytes for each group and
analyzed by high-performance liquid chromatography
(HPLC). One microliter was injected for precolumn
derivatization with ortho-phthaldialdehyde and analyzed
on an Amino Quant amino acid analyzer (Agilent Technol-
ogies GmbH, Deutschland) at the Protein Analysis Group
(Functional Genomics Center Zürich). The absolute
amounts of amino acids measured in the extracellular
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buffer are expressed as concentration [μM] of free amino
acid detected in the analyzed sample. Results were analyzed
using the GraphPad Prism 4 Software (San Diego, CA).
Tracer flux studies using X. laevis oocytes
Treatment and injection of oocytes was performed as
described previously [17]. Briefly, after injection of 5–
25 ng of cRNA (for wild-type or mutant transporter,
respectively), oocytes were incubated 2–3 days at 16°C in
ND96 solution. For efflux studies, oocytes were micro-
injected with [14C]-radiolabeled amino acid (∼10 nCi per
oocyte; Hartmann Analytic, Braunschweig, Germany).
After a brief wash with uptake buffer at RT, single oocytes
were incubated in 200 μl of uptake solution (10 mM
HEPES, pH 7.4, 100 mM NaCl, 2 mM KCl, 1 mM MgCl2,
and 1 mM CaCl2). Aliquots were collected at indicated
times, and transport of amino acids was terminated by
washing the individual oocytes five times with 2 ml of ice-
cold uptake buffer. To determine the retained radioactivity,
the oocytes were separately dissolved in 2% sodium
dodecyl sulfate (SDS, 250 μl) and shaken for 60 min.
Upon addition of scintillation cocktail (3 ml, Emulsifier-
Safe™), radioactivity was measured using a liquid scintil-
lation counter (TRI-CARB 2900TR, Packard Instrument).
The values were corrected for the volume of the incu-
bation solution and divided by the total amount of radio-
activity injected into the oocyte. This injected amount
(corresponding to 100%) was calculated for each oocyte
separately by adding the volume-corrected radioactivity
measured in the extracellular sample at the last time point,
radioactivity measured in the previous sample (60 min,
not corrected for volume), and the radioactivity remaining
in the oocyte. For graphical representation, raw data sets
were analyzed using the computer software GraphPad
Prism 4 (GraphPad Prism version 4.02, GraphPad soft-
ware). Statistical analysis was done using the two-tailed
paired t test or one-way analysis of variance followed by
Bonferroni’s multiple comparison post test, using GraphPad
Prism 4.
Antibodies
Affinity purified rabbit anti-mTAT1 antibody was used at a
dilution of 1:500 for Western blot analysis and 1:200 for
immunohistochemistry, as described before [22]. The other
antibodies used were previously characterized: rabbit anti-
mLAT2 antibody, serum SZ560 (dilution 1:1000 used for
Western blotting and 1:250 for immunohistochemistry)
[19], goat anti-m4F2hc (Santa Cruz Biotech, Santa Cruz,
CA, 1:500 dilution used for immunohistochemistry), and
mouse anti-h4F2hc (1 μg used per IP reaction) [24].
Secondary antibodies used for immunohistochemistry were
Alexa Fluor® 594 donkey anti-rabbit IgG (1:1000; Molec-
ular Probes, Portland, OR) and Alexa Fluor® 488 donkey–
anti-goat IgG (1:500; Molecular Probes), whereas, for
Western blot analysis, a goat anti-rabbit IgG conjugated to
Horseradish peroxidase was used as secondary antibody
(1:10,000; BD Transduction Laboratories, Lexington, KY).
Immunohistochemistry
Serial sections (4 μm) of perfused and frozen mouse kidney
were collected on polylysine-coated slides (O. Kindler
GmbH, Freiburg, Germany). Animals were killed according
to the Swiss Animal Welfare Laws and as approved by the
local Veterinary Authority (Kantonales Veterinäramt
Zürich). Immunostaining of tissue sections was carried out
as described previously [29]. Briefly, sections were rehy-
drated in a phosphate buffer solution (PBS) for 15 min at
RT, washed three times with PBS, and incubated with PBS
containing 1% bovine serum albumin for 15 min before
addition of the primary antibodies. Affinity-purified prima-
ry rabbit anti-mTAT1 antibody or rabbit anti-mLAT2 serum
together with affinity purified goat anti-m4F2hc antibody
were applied to the sections and incubated overnight at
4°C. Sections were then washed twice by immersion for
5 min in hypertonic PBS (PBS containing 2.7% NaCl)
and once in PBS before incubation with the secondary
antibody (Alexa Fluor® 594 donkey anti-rabbit IgG,
dilution 1:1000 and Alexa Fluor® 488 donkey–anti-goat
IgG, dilution 1:500) for 1 h at RT. Sections were washed
twice with hypertonic PBS, followed by a washing step
with PBS before mounting them with VectaMount
(Vector Laboratories, Burlingame, CA). Sections were
examined using a LEICA SP1 UV CLSM confocal micro-
scope. Pictures were processed and assembled using the
Imaris® 5.0.1 and Adobe Photoshop® 7.0 software.
Incubation of sections with only secondary antibodies did
not result in detection of signal and signal specificity of
anti-mTAT1 antibody was further confirmed by addition of
antigen peptides to primary antibodies before application
(data not shown).
Western blotting on oocyte protein lysates
Total membrane lysates of oocytes were prepared by
homogenization in an oocyte lysis buffer (250 mM sucrose,
0.5 mM ethylenediamine tetraacetic acid [EDTA], 5 mM
Tris–HCl, pH 6.9, 1 mM phenylmethylsulfonyl fluoride
(PMSF), and 1 μg/ml of leupept). Lysates were twice
centrifugated at 100g for 10 min, and the supernatants were
subjected to SDS-polyacrylamide gel electrophoresis (SDS-
PAGE). Proteins were subsequently transferred electropho-
retically from unstained gels to a polyvinylidene difluoride
(PVDF) membrane (Immobilon-P, Millipore, Bedford,
Pflugers Arch - Eur J Physiol (2007) 454:507–516 509
MA), blocked with 2% Top BLOCK™ powder (Juro,
Lucerne, Switzerland) and probed with indicated anti-
bodies as described. Chemiluminescence was detected
with a DIANA III camera (Raytest Schweiz, Dietikon,
Switzerland).
Immunoprecipitation, SDS-PAGE, and fluorography
Oocytes injected with indicated cRNAs were biosyntheti-
cally labeled with 1 mCi/ml L-[35S]-methionine for 2 days
of expression. After extensive washing with ND96, oocytes
were lysed by addition of 20 μl of EBC buffer (120 mM
NaCl, 50 mM Tris–HCl, pH 8.0, 0.5% NP-40, 1 mM
PMSF, and 10 μl/ml protease inhibitor cocktail [Sigma])
per oocyte and centrifuged at 12,000 rpm at 4°C for 10 min,
and supernatants were separated and precipitated with
trichloroacetic acid for determination of incorporation of
radioactivity. For the immunoprecipitation assay, 1 μg of
mouse monoclonal anti-h4F2hc antibody per reaction was
coupled to 30 μl of ImmunoPure® Immobilized Protein
A/G (Pierce, Rockford, IL). Protein lysates were precleared
by mixing with protein A/G agarose beads and rotating at
4°C for 1 h. Precleared protein lysates, containing equal
amounts of incorporated L-[35S]-methionine, were after-
wards mixed with anti-h4F2hc-coupled beads in EBC
buffer (500 μl) and incubated overnight at 4°C with
continuous rotation. Immunoprecipitated samples were
afterwards briefly centrifuged to pellet the beads, washed
six times with NET-N buffer (containing 20 mM Tris–HCl,
pH 8.0, 100 mM NaCl, 1 mM EDTA, and 0.5% NP40), and
resuspended in SDS-PAGE-loading buffer containing β-
mercaptoethanol. The samples were subsequently boiled for
5 min at 95°C and separated by SDS-PAGE. After
separation, proteins were either electrophoretically trans-
ferred to PVDF membrane or the gels were fixed and
stained with Coomassie Brilliant Blue R250, subsequently
treated with Amplify Fluorographic Reagent (Amersham
Biosciencies, Little Chalfont, Bucks, UK) for 30 min,
dried, and exposed to Fuji Super RX medical X-ray film
at −80°C.
Cell surface biotinylation and streptavidin precipitation
Cell-surface proteins of oocytes were labeled with cell-
membrane-impermeable and primary-amines-reactive sulfo-
NHS–LC–biotin (Pierce), according to the manufacturer’s
protocol. Briefly, oocytes were injected with indicated
cRNAs and kept at 16°C for 2–3 days. Subsequent steps
were done on ice, except mentioned otherwise. The oocytes
were washed in groups three times with ice-cold PBS,
pH 8.0, and afterwards incubated on ice for 30 min in
biotinylation solution containing 2 mM sulfo-NHS–LC–
biotin. The reaction was finally quenched by addition of
10 mM Tris–glycine, for 15 min. After washing six times
with ice-cold PBS, the oocytes were lysed as described
above. After a centrifugation step of 12,000 rpm for 10 min
at 4°C, supernatants containing total oocyte proteins were
transferred to new tubes and kept at −80°C. For streptavidin
precipitation, 40 μl of ImmunoPure® Immobilized Strepta-
vidin agarose beads were washed three times with TBS-
TWEEN20 (0.1%), mixed with 100 μl of total protein
oocyte lysates (approx. 4 μg/μl), and afterwards rotated for
4 h at 4°C. Samples were then washed six times with TBS-
TWEEN20, with a 1 min centrifugation step (3,000 rpm)
between washes. After the final wash, 4× SDS-PAGE
sample buffer was added, and samples were heated to 65°C
for 15 min and subjected to SDS-PAGE analysis. Protein
concentrations were determined according to the modified
method of Lowry (DC Protein Assay, Bio-Rad Laborato-
ries, California).
Crosslinking experiments
The crosslinking reagent 1,4-bis-maleimidobutane (BMB;
Pierce) has homobifunctional maleimide ends reactive
towards the sulfhydryl groups on proteins and peptides, in
a distance of 10.9 Å given by the noncleavable spacer arm.
The lyophilized crosslinker was dissolved in dimethyl
sulfoxide to 2.5 mM final concentration, before the reaction
setup. Optimization of reaction included titration of the
crosslinker concentration, as well as time course of
incubation (data not shown). The final conditions used for
the reaction mixture included 50 μg of total membranes
extracted from oocytes and 100 μM BMB crosslinker. The
reaction buffer used was PBS, pH 7.4. The samples were
treated with BMB for 1, 10, or 30 min at RT or left
untreated. Samples were subjected to SDS-PAGE analysis
using 6% acrylamide gel, electrophoretically transferred to
a PVDF membrane, and afterwards probed with anti-LAT2
or anti-TAT1 antibodies.
Results
TAT1 and LAT2-4F2hc are colocalized in the proximal
kidney tubule
Transepithelial transport of amino acids requires an active
uptake of amino acids at the luminal side of the epithelial
cell and their extrusion at the basolateral side. In the kidney
proximal tubule, expression of LAT2 that heterodimerizes
with 4F2hc was shown to be basolateral and to progres-
sively decrease towards the late segments of the proximal
tubule [2, 24]. Similarly, TAT1 was shown to be expressed
at the basolateral membrane of the kidney proximal tubule
epithelial cells in the S1 and S2 segments [22]. In this
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study, we show on consecutive sections of mouse kidney
that, as expected, TAT1 and LAT2-4F2hc proteins colo-
calize their signals starting from the glomerular capsule and
extending into the S1 and S2 segments of the proximal
tubule (Fig. 1).
Coexpression of TAT1 with the exchanger LAT2-4F2hc
induces efflux of L-glutamine and of other neutral amino
acids
The aromatic amino acid transporter TAT1 is known to
function as a facilitated diffusion pathway, whereas the
neutral amino acid transporter LAT2-4F2hc functions as an
obligatory exchanger [2, 17, 22]. To test the potential
functional cooperation of these transporters, we expressed
them individually and together in Xenopus oocytes. We
measured the efflux of radiolabeled L-Gln, which is a
known efflux substrate of LAT2 4F2hc but not of TAT1.
Figure 2a shows that oocytes preinjected with L-glutamine
released this amino acid into the amino-acid-free medium
(black bars) when both transporters were simultaneously
expressed. This observation is in line with the hypothesis
that TAT1 provides extracellular aromatic amino acids to
LAT2-4F2hc and that this latter exchanger transports them
back into the oocyte in exchange for effluxing L-glutamine.
The fact that LAT2-4F2hc was functionally expressed also
in the absence of TAT1 and could release L-glutamine in the
presence of sufficient influx substrate was demonstrated by
the rapid L-glutamine efflux from LAT2-4F2hc-expressing
oocytes upon addition of 2.5 mM L-phenylalanine to the
medium for 10 min at the end of the experiment (white
bars). The expression of both transporters was verified by
Western blotting (Fig. 2b).
The spectrum of amino acids released by Xenopus
oocytes expressing both TAT1 and LAT2-4F2hc was tested
by HPLC quantification of the amino acids accumulated in
the extracellular amino-acid-free medium within 24 h
(Fig. 3). As previously shown, the expression of TAT1
alone mediated an efflux of the three aromatic amino acids
independent of the presence of LAT2-4F2hc, as expected
for a facilitated diffusion pathway selective for aromatic
amino acids [22]. In contrast, as expected for a (near)
obligatory exchanger, the expression of LAT2-4F2hc alone
did not lead to a significant leak of any amino acid into the
media [17]. However, as shown in this paper, the co-
expression of these transport proteins led to an efflux of
L-glutamine, L-serine, L-asparagine, and L-alanine into the
medium that was statistically significant compared to that
from both oocytes expressing TAT1 or LAT2-4F2hc alone.
The additional efflux of L-histidine, L-threonine, and L-iso-
leucine did not reach a significant level. These results show
that all neutral amino acids that significantly leak into the
extracellular medium belong to the good efflux substrates
of LAT2-4F2hc and that they are the more concentrated
ones in oocytes [17, 26].
To test whether the additional efflux of neutral amino
acids from TAT1- and LAT2-4F2hc-coexpressing oocytes is
mediated by the functional cooperation of the two trans-
porters or, alternatively, is mediated by a modified transport
function of one of the two proteins because of the physical
presence of the other, we produced mutant transporters that
are defective in amino acid transport function but nonethe-
less are normally expressed at the cell surface. As shown in
Fig. 4a, the expression of either combination of functional
and mutant transporters did not induce the efflux of L-
glutamine, although Western blot analysis of surface-
biotinylated proteins (Fig. 4b) showed that both transporters
were expressed at the oocyte surface. Taken together, these
data strongly suggest that it is the combination of the
functions of TAT1 and LAT2-4F2hc that provides the efflux
pathway for L-glutamine.
Fig. 1 Basolateral colocalization of TAT1 and LAT2-4F2hc in the
epithelial cells of the mouse proximal kidney tubule. Expression and
subcellular localization of TAT1, LAT2, and 4F2hc was determined by
immunofluorescence microscopy. Two consecutive sections of frozen
mouse kidney were costained with anti-4F2hc (a) and anti-LAT2 (b)
or with anti-TAT1 (c) antibody, respectively
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TAT1 and LAT2-4F2hc appear not to interact physically
The functional cooperation of TAT1 with LAT2-4F2hc
suggested the possibility of a physical interaction of these
two transporters that would favor substrate channeling from
TAT1 to LAT2. To address this possibility, we tested
whether TAT1 could be coimmunoprecipitated with
LAT2-4F2hc. Lane 2 of Fig. 5 shows the proteins
immunoprecipitated with an anti-4F2hc antibody from a
lysate of oocytes expressing LAT2-4F2hc and TAT1
(fluorography of SDS-PAGE). 4F2hc appears as two bands,
one at ∼66 kDa corresponding to the core-glycosylated
form and around 85 kDa, the terminally glycosylated form,
whereas a single other band of ∼42 kDa is visible that
presumably corresponds to LAT2 [24]. Western blot
analysis of the same lysate used for immunoprecipitation
showed that both LAT2 (lane 4) and TAT1 (lane 8) were
present. In the 4F2hc immunoprecipitate, the catalytic
subunit of the heterodimer LAT2 was detected (lane 6)
but not TAT1 (lane 10).
To test the possibility that the physical proximity/
association of TAT1 with LAT2-4F2hc was missed by the
coprecipitation experiment, we submitted membranes of
coexpressing oocytes to crosslinking using a series of
different crosslinking agents, in particular glutaraldehyde,
DTSSP, DSP, DFDNB, BM(PEO)3, and BMB and ana-
Fig. 3 Coexpression of TAT1 and LAT2-4F2hc in Xenopus oocytes
induces efflux of L-Gln and other neutral amino acids. Free amino
acids, accumulated during 24 h in the extracellular buffer, were
separated by HPLC after derivatization and quantified as described in
“Materials and methods.” The mean values were obtained from five
independent groups of each 20 oocytes. NI stands for oocytes not
injected with cRNA. Error bars represent the SEM (*P<0.05 efflux
with LAT2-4F2hc and TAT1 significantly higher than with LAT2-
4F2hc or TAT1 alone; #P<0.05 efflux with LAT2-4F2hc and TAT1
significantly higher that with LAT2-4F2hc alone but not than with
TAT1)
Fig. 2 Coexpression of LAT2-4F2hc and TAT1 in Xenopus oocytes
induces efflux of L-Gln. a Oocytes injected with tracer amounts of
radiolabeled L-Gln were incubated in an uptake solution containing no
amino acids for 60 min (black bars). Transtimulation was induced for
additional 10 min by the addition of 2.5 mM L-Phe to the extracellular
buffer (white bars). Each bar represents the mean of 50–67 oocytes,
pooled from 12 different batches of oocytes. Error bars represent the
standard error of the mean (SEM; ***P<0.001) b Western blot
analysis of total protein lysates from a representative batch of oocytes.
PVDF membranes were probed with anti-LAT2 and anti-TAT1
antibodies, respectively. Molecular weight of marker proteins is
indicated in kilodaltons
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lyzed the proteins precipitated with anti-4F2hc antibody on
SDS-PAGE. As shown in Fig. 6, for the case of BMB, none
of the these agents crosslinked TAT1 to LAT2-4F2hc.
Taken together, the negative results of the coimmuno-
precipitation and crosslinking experiments suggest that
there is no close physical interaction between LAT2-
4F2hc and TAT1.
Functional cooperation of TAT1 or LAT2-4F2hc with other
transporters
We therefore tested whether the demonstrated function of
TAT1 to allowing L-glutamine efflux via LAT2-4F2hc
could be fulfilled by another facilitated diffusion amino
acid transporter. We chose to use for the substitution assay
LAT4 (Slc43a2). This L-type transporter is expressed,
unlike LAT2-4F2hc, in the distal nephron and does not
belong to the same structural family. It was shown to
transport L-phenylalanine, L-leucine, L-isoleucine, and L-
methionine and to mediate L-phenylalanine efflux indepen-
dent of the presence of extracellular amino acids [3].
Interestingly, upon coexpression of LAT4 with LAT2-
4F2hc, an efflux of L-glutamine was induced (Fig. 7a,
Fig. 6 Chemical crosslinking indicates no physical interaction
between LAT2-4F2hc and TAT1. Total membrane lysates extracted
from oocytes injected with LAT2-4F2hc, TAT1 (LT) cRNAs or not
injected (NI), were subjected to BMB crosslinking and separated by
SDS-PAGE. Duration of BMB crosslinking is given in minutes. LAT2
and TAT1 antibodies do not label the same bands. The main band
labeled by LAT2 antibody corresponds presumably to a heterotetramer
(2 LAT2-4F2hc heterodimers). The nature of the 130-kDa band
labeled by TAT1 antibody is not known and could represent an
oligomer
Fig. 5 TAT1 is not physically associated with 4F2hc or LAT2.
Coimmunoprecipitation was performed on lysates of biosynthetically
labeled oocytes coinjected with 4F2hc, LAT2, and TAT1 cRNAs (LT)
or not injected oocytes (NI). Precipitations with the anti-4F2hc
antibody were carried out in nonreducing conditions and separated
by SDS-PAGE. RX autoradiograph, WB Western blot on total lysate,
IP-4F2hc WB on immunoprecipitate
Fig. 4 Functionally inactive mutants of LAT2 (E257Q) and TAT1
(R340A) are expressed at the surface of Xenopus oocytes but do not
support L-Gln efflux. a Oocytes expressing wild-type (bold) and/or
mutant cRNA (italic, underlined) were injected with tracer amounts of
radiolabeled L-Gln and incubated as described previously (black bars
represent 60 min of L-Gln efflux; white bars represent 10 min of
subsequent transtimulation with 2.5 mM L-Phe). Each bar represents the
mean of 15–25 oocytes, pooled from five different batches. Error bars
represent the SEM. b Oocytes were surface biotinylated, lysates separated
by SDS-PAGE and probed with anti-LAT2 or anti-TAT1 antibodies
Pflugers Arch - Eur J Physiol (2007) 454:507–516 513
black bars) that was slightly but not significantly higher
than the sum of the effluxes observed with each transporter
expressed separately.
We also replaced the other component of the functional
couple, namely, the catalytic subunit of the heterodimeric
exhanger LAT2-4F2hc, with another catalytic subunit,
LAT1. Because L-glutamine is not a good efflux substrate
for this transporter, we measured the efflux of L-leucine
instead. Interestingly, this transporter combination was also
quite efficient and released, in the absence of extracellular
amino acids, significantly more L-leucine than either
transporter alone (Fig. 7b, black bars). Together with the
apparent lack of physical interaction of TAT1 with LAT2-
4F2hc, these results suggest that the coexpression of an
amino acid efflux pathway (facilitated diffusion transporters
TAT1 or LAT4) with an obligatory amino acid exchanger
(LAT2- or LAT1-4F2hc) can lead to a functional coopera-
tion independent of physical interaction.
Discussion
The present study shows that the expression of the aromatic
amino acid transporter TAT1 in the same membrane as the
obligatory exchanger of neutral amino acids LAT2-4F2hc
leads to an efflux of several neutral amino acids into the
amino-acid-free medium. It is suggested that the efflux
pathway used by these amino acids is the obligatory
exchanger LAT2-4F2hc. This hypothesis is strongly sup-
ported by the fact that the function of both surface-
expressed transporters is necessary and that the amino
acids released additionally to the aromatic TAT1 substrates
are all known LAT2-4F2hc efflux substrates [17]. An
additional argument is that upon replacing the obligatory
exchanger LAT2-4F2hc by the other neutral amino acid
obligatory exchanger LAT1-4F2hc, we observe a more
efficient release of the typical LAT1-4F2hc efflux substrate
L-leucine than of L-glutamine, which is not a good LAT1-
4F2hc efflux substrate (Fig. 7b, data now shown, and [17]).
Together, these experiments indeed very strongly suggest
that it is the functional cooperation of TAT1 with LAT2-
4F2hc that leads to this new efflux function. Aromatic
amino acids released extracellulary by TAT1 would
function as an influx substrate for LAT2-4F2hc and thereby
allow the efflux of other amino acids via this obligatory
exchanger. In the following paragraphs, we will discuss a
few questions that arise from this suggested functional
cooperation of TAT1 with LAT2-4F2hc.
The first question is why, from the efflux substrates of
LAT2-4F2hc, it is in particular L-glutamine, L-asparagine,
L-serine, and L-alanine that accumulate over 24 h in the
extracellular medium of oocytes expressing LAT2-4F2hc
and TAT1. We suggest that the major reason that favors a
high long-term efflux rate of specifically these four amino
acids is the fact that they are nonessential and can be
produced in the oocytes from abundant precursors. In
contrast, all other LAT2-4F2hc efflux substrates that do not
significantly accumulate outside of the oocytes are essential
amino acids present in limited amounts within oocytes,
with the exception of glycine [26].
The second question arising from the functional cooper-
ation of LAT2-4F2hc with TAT1 is why it is specifically an
Fig. 7 Substitution assays indicate that other combinations of an
exchanger with a facilitated diffusion transporter can lead to functional
cooperation. a Oocytes expressing LAT4 instead of TAT1, with LAT2-
4F2hc, were injected with radiolabeled L-Gln, incubated for 60 min in
amino-acid-free medium (black bars) and subsequently transtimulated
by L-Phe (white bars). Each bar represents the mean of 17–25 oocytes
pooled from three to five different experiments. b Following the same
protocol, efflux of radiolabeled L-Leu by oocytes coexpressing LAT1-
4F2hc, instead of LAT2-4F2hc, together with TAT1 was measured.
Each bar represents the mean of eight to ten oocytes pooled from two
different experiments. Error bars represent the SEM (ns, not
significant, P>0.05; ***P<0.001)
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aromatic amino acid transporter that controls the efflux via
the exchanger LAT2-4F2hc. We suggest here two non-
mutually exclusive possibilities. First, from the point of
view of organism nutrition and extracellular amino acid
homeostasis, it appears meaningful that the amino acid
efflux function of (transporting) cells be regulated accord-
ing to essential amino acid levels, because they depend on
the protein nutritional state [7, 8]. Second, it might be that
physico-chemical properties of aromatic amino acids, in
particular, low affinity binding to proteins and/or mem-
branes [25], might be an advantage for their recycling
function. It can be envisaged that this type of interaction
might favor the maintenance of higher local aromatic amino
acid concentrations that would facilitate substrate channel-
ing through the cell-surface-unstirred layer to neighboring
transporters.
A third question of importance regarding the proposed
functional cooperation of the TAT1 with LAT2-4F2hc is the
fact that the concentrations of substrate amino acids
necessary to substantially activate LAT2-4F2hc from the
outside is clearly much higher than the extracellular amino
acid concentrations measured in the present experiments
[17]. This discrepancy suggested to us the possibility of a
physical interaction between TAT1 and LAT2-4F2hc.
However, none of the coimmunoprecipitation and cross-
linking experiments that we performed (Figs. 5, 6, and data
not shown) supported such a hypothesis. Thus, we conclude
that the mere proximity of the transporters within the same
membrane domain must be sufficient. In the case of the
Xenopus oocytes, as in basolateral membranes of epithelial
cells, the membrane surface is not flat, and there is a surface
layer of extracellular fluid that forms an unstirred layer in
which the concentration of solutes effluxing from the cells
can be much higher than in the bulk solution [12]. Further-
more, as mentioned below, it is possible that solute-specific
physico-chemical properties might favor this type of con-
centration difference between bulk fluid and the membrane-
contiguous unstirred layer [21].
A fourth question arising from the proposed functional
cooperation of TAT1 with LAT2-4F2hc is why evolution
has favored for the basolateral efflux of neutral and cationic
amino acids, as well as in many other cases of transmem-
brane amino acid transports, the use of obligatory exchang-
ers such as the 4F2hc-associated transporters LAT2 and
y+LAT1. Plausible reasons could be that these exchangers
are, on the one hand, optimal to maintain similar relative
concentrations of the different substrate amino acids on
both sides of membranes even in the presence of large
absolute concentration differences and, on the other hand,
that their function in the context of net transport can be
controlled easily by one (or a few) unidirectionally
functioning transporter(s) expressed in the same membrane.
We suggest that TAT1, as a facilitated diffusion pathway for
aromatic amino acids, can play such a regulatory role, as its
net transport function depends on the transmembrane
aromatic amino acid concentration difference.
A fifth question, relating to the suggested role of TAT1
with amino acid exchangers in controlling the amino acid
efflux via LAT2-4F2hc and possibly also via the cationic
amino acid efflux pathway y+LAT1-4F2hc, is whether
TAT1 needs to be highly regulated at the level of its
function and/or expression. The first answer to this question
is that substrate-dependent regulation is provided by the
kinetic behavior of TAT1 as a facilitated diffusion pathway
with relatively low apparent affinity for its substrates.
However, its expression level certainly has a major impact
on the velocity and extent of the regulatory reaction toward
transmembranous concentration difference in aromatic
amino acids. Thus, besides the certainly important kinetic
aspect of the TAT1 regulatory function, it is likely that this
transporter is also tightly regulated at its expression level.
In that respect, it is interesting to notice that compared to
most other member of the Slc16 family, TAT1 has a long
NH2-terminal cytoplasmic tail that contains so-called PEST
(proline, glutamic acid, serine, or threonine) sequences.
This amino acid sequence pattern is indicative of a possible
rapid and eventually regulated ubiquitin-mediated turnover
[1, 16, 23]. Thus, further experiments are required to test
this possibility.
Taken together, our data strongly suggest that by
allowing aromatic amino acids to efflux, TAT1 provides
the obligatory exchanger LAT2-4F2hc with influx sub-
strates and thereby controls the net efflux of other neutral
amino acids.
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